These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5028365)

  • 1. [Clinical evaluation of Intenkordin].
    Markiewicz M; Korolko A; Hruczkowska E
    Pol Tyg Lek; 1972 May; 27(21):796-8. PubMed ID: 5028365
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of sedo-intensain in the treatment of coronary angor].
    Steenhouwer B
    Lille Med; 1968 Oct; ():Suppl 6:815+. PubMed ID: 5748100
    [No Abstract]   [Full Text] [Related]  

  • 3. [Importance of carbocromen in the treatment of anginal pain].
    Baledent M; Dutrieux JP; Marguery J; Delmaire M
    Lille Med; 1968 Oct; ():Suppl 6:808+. PubMed ID: 5748099
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intensain treatment of patients with ischemic heart disease].
    Kuzko NV
    Vrach Delo; 1972 Apr; 4():40-3. PubMed ID: 5048948
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new anti-stenocardiac agent: carbochromen].
    Arcidiacono R; Sanna GP; Fornasero L
    Minerva Cardioangiol; 1971 Dec; 19(12):719-28. PubMed ID: 5129038
    [No Abstract]   [Full Text] [Related]  

  • 6. [Carbochromen in treatment of coronary arterial disease].
    Szczepański L; Wnukowska M; Dmoszyńska A
    Wiad Lek; 1974 Mar; 27(5):463-6. PubMed ID: 4603373
    [No Abstract]   [Full Text] [Related]  

  • 7. [Carbochromene in ischemic heart disease].
    Maresca FS; De Luca A
    Minerva Cardioangiol; 1973 May; 21(5):386-9. PubMed ID: 4575717
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of coronary insufficiency by carbocromen (apropos of 40 cases)].
    Queneau P; Le Guyader J; Pont M
    Rev Lyon Med; 1967 Nov; 16(18):753-7. PubMed ID: 5621963
    [No Abstract]   [Full Text] [Related]  

  • 9. [Side effect of intensaine].
    Kurochkin NM; Belolipetskaia TA; Stepashkin AM
    Sov Med; 1973 Jul; 36(7):141. PubMed ID: 4776693
    [No Abstract]   [Full Text] [Related]  

  • 10. [Carbochromen in treatment of coronary arterial disease].
    Szczepański L; Wnukowska M; Dmoszyńska A
    World Health Organ Tech Rep Ser; 1974 Mar; 27(5):463-6. PubMed ID: 4206990
    [No Abstract]   [Full Text] [Related]  

  • 11. Antianginal effects of chromonar. A combined investigation.
    Bing RJ; Bender SR; Dunn MI; Fry GA; Fuller WM; Liu SC; Miller HS; Moses JW; Ritzmann LW; Segal JP; Shugoll GI; Tillmanns H; Wallace A
    Clin Pharmacol Ther; 1974 Jul; 16(1):4-13. PubMed ID: 4210514
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial of the Cardiocap R capsule with prolonged action in myocardial infarct and coronary insufficiency].
    Sarnari V; Garassini G
    Minerva Cardioangiol; 1973 Nov; 21(11):732-7. PubMed ID: 4776568
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of Intencordin treatment of patients with coronary artery disease].
    Adamska-Dyniewska H; Goch JH; Gajewska B
    Wiad Lek; 1973 Oct; 26(20):1937-40. PubMed ID: 4587344
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical study comparing the effect of small doses of heparin with the effects of carbocromen and pentaerythrityl tetranitrate in angina pectoris. Some questions of the therapeutical mechanism of heparin.
    Goldberg GA; Suriadnova BA; Stepanov MA; Kochanko EP
    Cor Vasa; 1972; 14(2):81-95. PubMed ID: 5050956
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of therapeutic effects of coronary drugs in the USSR.
    Simonson E; Berman R
    Am Heart J; 1971 Nov; 82(5):684-6. PubMed ID: 4940222
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experimentation with Cardiocap in subjects with coronary disease with coronary insufficiency].
    Marignani A; Martelli A; Piana G
    Minerva Cardioangiol; 1973 Sep; 21(9):629-35. PubMed ID: 4745005
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dosed physical loading as a method of evaluating the results of treating ischemic heart disease].
    Ol'binskaia LI; Ovchinnikova LV
    Kardiologiia; 1972 Dec; 12(12):32-6. PubMed ID: 4196637
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of coronary insufficiency with a combination of a coronary dilator and a beta-adrenergic blockader].
    Grujić M; Perinović M
    Med Arh; 1972; 26(4):267-70. PubMed ID: 4405711
    [No Abstract]   [Full Text] [Related]  

  • 19. [A side effect of Intensain].
    Gofman LI
    Klin Med (Mosk); 1971 Aug; 49(8):142-3. PubMed ID: 5127448
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of intensain on several indices of the blood coagulation and anti-coagulation system in patients with stenocardia].
    Abdulaeva LD
    Ter Arkh; 1972 Jan; 44(1):42-5. PubMed ID: 5017537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.